Suppr超能文献

人B细胞克隆可被白细胞介素4和活化的CD4+T细胞克隆提供的信号诱导增殖,并转换为合成IgE和IgG4。

Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones.

作者信息

Gascan H, Gauchat J F, Roncarolo M G, Yssel H, Spits H, de Vries J E

机构信息

Human Immunology Department, DNAX Research Institute for Molecular and Cellular Biology, Palo Alto, California 94304.

出版信息

J Exp Med. 1991 Mar 1;173(3):747-50. doi: 10.1084/jem.173.3.747.

Abstract

In the present study, it is demonstrated that cloned surface IgM-positive human B cells can be induced to proliferate and to switch with high frequencies to IgG4 and IgE production after a contact-mediated signal provided by T cell clones and interleukin 4 (IL-4). This T cell signal is antigen nonspecific and is provided by activated CD4+ cells, whereas activated CD8+ or resting CD4+ T cell clones are ineffective. 15-35% of the B cell clones cultured with cloned CD4+ T cells and IL-4 produced antibodies; 35-45% of those wells in which antibodies were produced contained IgE and IgG4. In addition to B cell clones that produced IgG4 or IgE only, B cell clones producing multiple isotypes were observed. Simultaneous production of IgG4 and IgE, IgM, IgE, and IgM, or IgG4 and IgE was detected, suggesting that during clonal expansion switching might occur in successive steps from IgM to IgG4 and IgE. In addition, production of only IgM, IgG4, and IgE during clonal expansion indicates that this isotype switching is directed by the way a B cell is stimulated and that it is not a stochastic process.

摘要

在本研究中,已证明克隆的表面IgM阳性人B细胞在T细胞克隆和白细胞介素4(IL-4)提供的接触介导信号后,可被诱导增殖并高频转换为产生IgG4和IgE。这种T细胞信号是非抗原特异性的,由活化的CD4+细胞提供,而活化的CD8+或静止的CD4+T细胞克隆则无效。用克隆的CD4+T细胞和IL-4培养的B细胞克隆中有15-35%产生抗体;产生抗体的孔中有35-45%含有IgE和IgG4。除了仅产生IgG4或IgE的B细胞克隆外,还观察到产生多种同种型的B细胞克隆。检测到同时产生IgG4和IgE、IgM和IgE或IgG4和IgM,这表明在克隆扩增过程中,转换可能从IgM到IgG4和IgE分连续步骤发生。此外,在克隆扩增过程中仅产生IgM、IgG4和IgE表明这种同种型转换是由B细胞被刺激的方式所指导的,而不是一个随机过程。

相似文献

引用本文的文献

1
Update on the Treatment of Chronic Spontaneous Urticaria.慢性自发性荨麻疹的治疗进展
Drugs. 2025 Apr;85(4):475-486. doi: 10.1007/s40265-025-02170-4. Epub 2025 Mar 12.
8
Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis.抑制特应性皮炎中2型炎症的当前及新出现策略
Dermatol Ther (Heidelb). 2022 Jul;12(7):1501-1533. doi: 10.1007/s13555-022-00737-7. Epub 2022 May 21.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验